Table of Contents
INTRODUCTION
I. EXECUTIVE SUMMARY
II. MARKET ENVIRONMENT
- General
- Macroeconomic Outlook
- Demographic Trends
- Health Care Trends
- Medical Conditions
- Chronic Conditions
- Acute Conditions
- Health Insurance & Reimbursement
- National Health Expenditures
- Medical Providers
- Hospitals
- Outpatient Facilities
- Physicians
- Dentists
- Other Health Care Providers
- Patient Activity
- Surgical Procedures
- Outpatient Visits
- Diagnostic Tests
- Medical Product Demand
- Pharmaceuticals
- Diagnostic Products
- In Vitro Diagnostic (IVD) Products
- In Vivo Imaging Agents
- Medical Supplies & Devices
III. NANOTECHNOLOGY OVERVIEW
- General
- Product Groups
- Regulatory Trends
- Pharmaceuticals
- Diagnostic Products
- Medical Supplies & Devices
- Current Good Manufacturing Practices (cGMPs)
- Investment Environment
- International Markets
IV. NANOMATERIALS
- General
- Monoclonal Antibodies
- DNA Materials
- Nanoparticles
- Nanotubes & Nanowires
- Dendrimers
- Fullerenes
- Quantum Dots
- Other Nanomaterials
V. NANOMEDICINES
- General
- Product Groups
- Monoclonal Antibodies
- Marketed Products
- Products in Development
- Polymer-Based Nanomedicines
- Marketed Products
- Developmental Activities
- Other Nanomedicines
- Nanocrystal Therapies
- Liposomes
- Marketed Products
- Products in Development
- All Other Nanomedicines
- Marketed Products
- Products in Development
VI. NANODIAGNOSTICS
- General
- In Vitro Diagnostics
- Monoclonal Antibodies
- Immunological Reagents & Test Kits
- Immunohematology
- Cellular Analysis
- Research Reagents
- DNA Testing Materials
- Amplified DNA Probes
- Direct DNA Probes
- DNA Microarrays
- Other DNA Testing Materials
- In Vivo Diagnostics
- MRI Imaging Agents
- Advanced Magnetics
- Kereos
- Other Development Stage Compounds
- Other Diagnostic Imaging Agents
VII. NANOTECH MEDICAL SUPPLIES & DEVICES
- General
- Orthopedic Products
- Bone Cement
- Bone Substitutes
- Orthopedic Implants
- Wound Management Products
- Wound Closures
- Wound Dressings
- Dental Products
- Surgical Products
- Ophthalmic Products
- Other Nanotechnology Medical Supplies & Devices
- Disinfectants
- Cardiac Implants
- Cochlear Implants
- Catheters
- Neuron Regenerators
- Artificial Skin
VIII. APPLICATIONS
- General
- Cancer
- Epidemiological Trends
- Nanomedicines
- Diagnostics
- Central Nervous System Conditions
- Epidemiological Trends
- Nanomedicines
- Diagnostics
- Medical Supplies & Devices
- Infective & Parasitic Conditions
- Epidemiological Trends
- Nanomedicines
- Diagnostics
- Cardiovascular Conditions
- Epidemiological Trends
- Nanomedicines
- Diagnostics
- Medical Supplies & Devices
- Other Applications
IX. INDUSTRY STRUCTURE
- General
- Market Share
- Competitive Strategies
- Licensing Agreements
- Research & Development
- Marketing & Distribution
- Manufacturing
- Company Profiles
- Abbott Laboratories
- Abraxis BioScience Incorporated
- Access Pharmaceuticals Incorporated
- Advanced Magnetics Incorporated
- Advion BioSciences Limited
- Alnis BioSciences Incorporated
- Altair Nanotechnologies Incorporated
- ALZA Corporation, see Johnson & Johnson
- American BioScience, see Abraxis BioScience
- American Pharmaceutical Partners, see Abraxis BioScience
- Amgen Incorporated
- Angstrom Medica Incorporated
- Arrowhead Research Corporation
- AstraZeneca plc
- Avidimer Therapeutics Incorporated
- Baxter International Incorporated
- Bayer AG
- BioDelivery Sciences International
- BioForce Nanosciences Holdings Incorporated
- Biogen Idec Incorporated
- Biophan Technologies Incorporated
- BioSante Pharmaceuticals Incorporated
- BioTrove Incorporated
- Bristol-Myers Squibb Company
- C Sixty, see Carbon Nanotechnologies
- Carbon Nanotechnologies Incorporated
- CritiTech Incorporated
- Crystalplex Corporation
- CytImmune Sciences Incorporated
- Danaher Corporation
- Dendritic NanoTechnologies, see Starpharma Holdings
- Dow Chemical Company
- Elan Corporation plc
- Enzon Pharmaceuticals Incorporated
- eSpin Technologies Incorporated
- Ferro Corporation
- Flamel Technologies SA
- GeneFluidics Incorporated
- Genentech Incorporated
- Health Plus International Incorporated
- Improvita Health Products Incorporated
- Insert Therapeutics, see Arrowhead Research
- International Business Machines Corporation
- Intradigm Corporation
- Introgen Therapeutics Incorporated
- Invitrogen Corporation
- Johnson & Johnson
- Kerr Corporation, see Danaher Corporation
- Lavipharm Corporation
- Luna Innovations Incorporated
- Mallinckrodt, see Tyco International
- Merck & Company Incorporated
- Mersana Therapeutics Incorporated
- NanoBio Corporation
- NanoBioMagnetics Incorporated
- NanoBioTec GmbH
- Nanobiotix SA
- NanoCarrier Company Limited
- NanoCure Corporation, see Avidimer Therapeutics
- NanoDel Technologies GmbH
- Nanodisc Incorporated
- Nanogen Incorporated
- NanoHorizons Incorporated
- NanoInk Incorporated
- NanoLab
- NanoMaterials Technology Pte Limited
- NanoMed Pharmaceuticals Incorporated
- Nanomix Incorporated
- Nanopharma Corporation, see Mersana Therapeutics
- Nanoplex Technologies, see Oxonica Limited
- Nanospectra Biosciences Incorporated
- Nanosys Incorporated
- Nektar Therapeutics
- Novagali Pharma SA
- Novavax Incorporated
- NUCRYST Pharmaceuticals Corporation
- Ortho Biotech Products, see Johnson & Johnson
- Orthovita Incorporated
- Oxonica Limited
- Pfizer Incorporated
- PharmaSol GmbH
- pSivida Limited
- Quantum Dot, see Invitrogen Corporation
- Roche Holding Limited
- Salvona LLC
- Sensatex Incorporated
- Siemens AG
- SkyePharma plc
- Smiths Group plc
- Soliqs, see Abbott Laboratories
- Spire Corporation
- Starpharma Holdings Limited
- Sybron Dental Specialties, see Danaher
- Tailored Materials Corporation Incorporated
- Teva Pharmaceutical Industries Limited
- 3M Company
- Triton BioSystems Incorporated
- Tyco International Limited
- Wyeth
LIST OF TABLES
SECTION I -- EXECUTIVE SUMMARY
SECTION II -- MARKET ENVIRONMENT
- 1 Macroeconomic Indicators
- 2 Population by Age Group
- 3 Medical Conditions by Duration & Type
- 4 National Health Expenditures by Type
- 5 Selected Medical Providers by Type
- 6 Selected Patient Activity by Type
- 7 Medical Product Demand by Type
- 8 Pharmaceutical Demand by Therapeutic Class
- 9 Diagnostic Product Demand by Type
SECTION III -- NANOTECHNOLOGY OVERVIEW
- 1 Nanotechnology Medical Product Demand by Type
- 2 R&D Investment in Nanotechnology Medical Products
SECTION V -- NANOMEDICINES
- 1 Nanomedicine Demand by Therapeutic Class
- 2 Nanomedicine Demand by Product Group
- 3 Therapeutic Monoclonal Antibody Demand
- 4 Therapeutic Monoclonal Antibodies Approved for US Sale
- 5 Therapeutic Monoclonal Antibodies -- US Sales by Product, 2001 & 2006
- 6 Polymer-Based Nanomedicine Demand
- 7 Polymer-Based Nanomedicines Approved for US Sale
- 8 Polymer-Based Nanomedicines -- US Sales by Product, 2001 & 2006
- 9 Other Nanomedicine Demand
- 10 Nanocrystal Medicines Approved for US Sale
- 11 Liposomal Therapies Approved for US Sale
- 12 Other Nanomedicines Approved for US Sale
SECTION VI -- NANODIAGNOSTICS
- 1 Nanotechnology-Based Diagnostic Product Demand by Segment
- 2 Nanotechnology In Vitro Diagnostic Product Demand by Type
- 3 Monoclonal Antibody-Based Diagnostic Product Demand by Type
- 4 Monoclonal Antibody-Based Immunological Reagent & Test Kit Demand
- 5 Monoclonal Antibody-Based Immunohematology Reagent & Test Kit Demand
- 6 Monoclonal Antibody-Based Cellular Analysis Reagent & Test Kit Demand
- 7 Monoclonal Antibody-Based Research Reagent Demand
- 8 DNA Testing Material Demand by Type
- 9 Amplified DNA Probe Demand
- 10 Direct DNA Probe Demand
- 11 DNA Microarray Demand
- 12 Other DNA Testing Material Demand by Type
- 13 Nanotechnology In Vivo Diagnostic Product Demand
SECTION VII -- NANOTECH MEDICAL SUPPLIES & DEVICES
- 1 Nanotechnology Medical Supply & Device Demand by Product Group
- 2 Nanotechnology Orthopedic Product Demand
- 3 Nanopolymer Bone Cement Demand
- 4 Nanomaterial Bone Substitute Demand
- 5 Nanotechnology Orthopedic Implant Demand by Type
- 6 Nanotechnology Wound Management Product Demand
- 7 Nanotechnology Wound Closure Demand
- 8 Nanotechnology Wound Dressing Demand
- 9 Nanotechnology Dental Product Demand
- 10 Nanotechnology Surgical Product Demand
- 11 Nanotechnology Ophthalmic Product Demand
- 12 Other Nanotechnology Medical Supply & Device Demand
SECTION VIII -- APPLICATIONS
- 1 Nanotechnology Medical Product Demand by Application
- 2 Nanotechnology Cancer Product Demand
- 3 Nanotechnology Central Nervous System Product Demand
- 4 Nanotechnology Product Demand for Infective & Parasitic Conditions
- 5 Nanotechnology Cardiovascular Product Demand
- 6 Nanotechnology Medical Product Demand in Other Applications by Product
Class & Type
SECTION IX -- INDUSTRY STRUCTURE
- 1 Selected Cooperative Agreements
LIST OF CHARTS
SECTION III -- NANOTECHNOLOGY OVERVIEW
- 1 Nanotechnology Medical Product Demand by Type, 2011
SECTION V -- NANOMEDICINES
- 1 Nanomedicine Demand by Therapeutic Class, 2011
- 2 Nanomedicine Demand by Product Group, 2011
SECTION VI -- NANODIAGNOSTICS
- 1 Nanodiagnostics Demand by Product Group, 2011
SECTION VII -- NANOTECH MEDICAL SUPPLIES & DEVICES
- 1 Nanotech Medical Supply & Device Demand by Product Group, 2011
SECTION VIII -- APPLICATIONS
- 1 Nanotechnology Medical Product Demand by Application, 2011
SECTION IX -- INDUSTRY STRUCTURE
- 1 Nanotechnology Medical Product Market Share, 2006
|
Related Report
|
View Cart
